Literature DB >> 24165814

Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation.

Daniel N Gotthardt1, Karl Heinz Weiss, Christian Rupp, Konrad Bode, Isabella Eckerle, Gerda Rudolph, Janine Bergemann, Petra Kloeters-Plachky, Fadi Chahoud, Markus W Büchler, Peter Schemmer, Wolfgang Stremmel, Peter Sauer.   

Abstract

BACKGROUND AND STUDY AIMS: To determine the importance of bacteriobilia and fungibilia in patients with endoscopic treatment of biliary complications after orthotopic liver transplantation (OLT). PATIENTS AND METHODS: In a prospective study at a tertiary center, 213 patients underwent 857 endoscopic retrograde cholangiographies (ERCs) after OLT. Findings at first ERC were: anastomotic stricture in 24.4%, nonanastomotic stricture in 18.3%, leakage in 11.3%, and gallstones in 4.7%.
RESULTS: Bile samples from first ERC showed Gram-positive bacterial isolates in 102/180 (57%) and Gram-negative in 44/180 (24%). Main species were Enterococcus spp. (40%; 72/180) and Escherichia coli (10%; 18 /180). Enteric bacteria (present in 47%) and Candida spp. (present in 18%) were both associated with clinical signs of cholangitis, but not with laboratory signs of inflammation. Multiresistant strains (present in 12% of samples) showed no association with clinical or laboratory parameters. Detection of microbiological isolates was independent of endoscopic findings and treatment. In patients with successful endoscopic intervention, the actuarial survival free of retransplantation was significantly lower in those with detection of enteric bacteria, being 51.8 months (95% confidence interval [CI] 42.9-60.6) vs. 62.9 months (95% CI 59.1-66.7); P = 0.025). Fungibilia was associated with significantly lower actuarial retransplantation-free survival, independently of successful endoscopic treatment (mean 35.1 months [95% CI 23.5-46.7] vs. 53.1 months [(95% CI 48.0-58.2]; P = 0.019).
CONCLUSIONS: Bacteriobilia and fungibilia can frequently be detected by routine microbiological sampling in patients after OLT. Regular bile sampling is recommended since the presence of difficult-to-treat multiresistant strains is unpredictable. Survival is affected by this altered biliary microbiological environment after OLT. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24165814     DOI: 10.1055/s-0033-1344713

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  12 in total

1.  Risk factors of organ failure in cholangitis with bacteriobilia.

Authors:  Jae Min Lee; Sang Hyub Lee; Kwang Hyun Chung; Jin Myung Park; Ban Seok Lee; Woo Hyun Paik; Joo Kyung Park; Ji Kon Ryu; Yong-Tae Kim
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  Location of a biliary leak after liver resection determines success of endoscopic treatment.

Authors:  Anja Schaible; Peter Schemmer; Thilo Hackert; Christian Rupp; Anna E Schulze Schleithoff; Daniel N Gotthardt; Markus W Büchler; Peter Sauer
Journal:  Surg Endosc       Date:  2016-08-17       Impact factor: 4.584

Review 3.  [Bacterial hepatobiliary infections : Pathogen spectrum, antimicrobial resistance and current treatment concepts].

Authors:  Tony Bruns; Andreas Stallmach
Journal:  Internist (Berl)       Date:  2022-03-03       Impact factor: 0.743

4.  Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis.

Authors:  Christian Rupp; Konrad Alexander Bode; Fadi Chahoud; Andreas Wannhoff; Kilian Friedrich; Karl-Heinz Weiss; Peter Sauer; Wolfgang Stremmel; Daniel Nils Gotthardt
Journal:  BMC Infect Dis       Date:  2014-10-23       Impact factor: 3.090

5.  Epidemiology and Resistance Patterns of Bacterial and Fungal Colonization of Biliary Plastic Stents: A Prospective Cohort Study.

Authors:  Christoph Lübbert; Karolin Wendt; Jürgen Feisthammel; Annette Moter; Norman Lippmann; Thilo Busch; Joachim Mössner; Albrecht Hoffmeister; Arne C Rodloff
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

6.  Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study.

Authors:  Hella Wobser; Agnetha Gunesch; Frank Klebl
Journal:  BMC Gastroenterol       Date:  2017-01-13       Impact factor: 3.067

7.  Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.

Authors:  Philipp A Reuken; Dorian Torres; Michael Baier; Bettina Löffler; Christoph Lübbert; Norman Lippmann; Andreas Stallmach; Tony Bruns
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

8.  Single-operator cholangioscopy for biliary complications in liver transplant recipients.

Authors:  Anna Hüsing-Kabar; Hauke Sebastian Heinzow; Hartmut Hans-Jürgen Schmidt; Carina Stenger; Hans Ulrich Gerth; Michele Pohlen; Gerold Thölking; Christian Wilms; Iyad Kabar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

9.  Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction.

Authors:  Georg-Martin Haag; Thomas Herrmann; Dirk Jaeger; Wolfgang Stremmel; Peter Schemmer; Peter Sauer; Daniel Nils Gotthardt
Journal:  BMC Gastroenterol       Date:  2015-12-04       Impact factor: 3.067

10.  Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

Authors:  Annika Gauss; Peter Sauer; Adolf Stiehl; Christian Rupp; Johannes Krisam; Yvonne Leopold; Petra Kloeters-Plachky; Wolfgang Stremmel; Daniel Gotthardt
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.